SB 579 requires Maryland counties with volunteer fire companies to provide no-cost preventive cancer screenings to volunteer firefighters, based on guidelines from the International Association of Fire Fighters. Volunteer fire companies must maintain and annually submit updated lists of their members to the county, which must then keep these records. Counties can meet this requirement by offering annual exams including cancer screenings or applying for specific grants to fund innovative screening technologies. The bill directly affects volunteer firefighters and counties, creating a structured process for access to preventive care without cost to the firefighters.
HB 1012 authorizes counties and municipalities in Maryland to establish local suicide fatality review teams, which directly affect local governments and public health agencies. These teams must include representatives from health departments, law enforcement, schools, hospitals, and mental health professionals to review suicide cases and identify systemic factors. The bill requires teams to coordinate with the state suicide review committee and mandates confidentiality for case discussions, exempting meetings about individual cases from public disclosure laws and protecting sensitive information. It also prohibits public disclosure of identifying details about deceased individuals or those affected by suicide, ensuring privacy while allowing teams to develop prevention recommendations.
SB 719 restricts the land application of sewage sludge containing per- and polyfluoroalkyl substances (PFAS) above specific concentration levels, effective after a set date. It requires monitoring for PFAS in sewage sludge and products containing it, authorizes stricter pretreatment rules for industrial users discharging PFAS, and allows local jurisdictions to set fees for such discharges. The bill directly affects sewage sludge generators (like wastewater treatment facilities), industrial users, and local regulators by mandating new PFAS testing, usage limits, and fee structures. It amends Maryland’s environmental code to establish these requirements without changing existing land application rules for sludge below the new PFAS thresholds.
SB 707 amends Maryland's Mental Health Law to clarify the definition of "danger to the life or safety of the individual or of others" for involuntary admission and emergency evaluations. It specifies that this danger includes four key scenarios: causing bodily harm, engaging in conduct likely to result in criminal justice involvement, inability to meet basic needs (food, shelter, medical care) creating serious risk, or substantial deterioration in judgment preventing informed treatment decisions. The bill directly affects individuals with mental disorders who may be assessed for involuntary care, as well as healthcare providers making those determinations under the law. This definition replaces the current standard in Maryland Code, Section 10-601, and takes effect October 1, 2026.
HB 771 requires Maryland health occupations boards to allow license renewal credits for free, 1-hour human trafficking awareness training. The training must cover definitions of trafficking, trauma-informed care, health indicators, screening protocols, reporting requirements, and survivor resources. It directly affects health practitioners (like nurses and therapists) needing license renewals, with boards mandated to adopt regulations by October 2026. The Maryland Department of Health must approve the training program by July 2026 in collaboration with universities and anti-trafficking organizations. The bill takes effect June 1, 2026.
HB 1192 expands Maryland's State Board of Sign Language Interpreters from 7 to 11 members, requiring specific representation including deaf individuals, deafblind people, licensed interpreters from various settings (medical, legal, educational), and agency owners. The bill delays the deadline for the Board to establish licensing requirements from July 1, 2024, to December 31, 2026, and sets new rules for member removal if they miss meetings, fail to meet qualifications, or commit misconduct. Sign language interpreters in Maryland who provide services in the state will be directly affected by the updated licensing requirements and the Board's new structure. The bill also mandates that appointed members reflect Maryland's racial and geographic diversity where practicable.
SB 645 restructures Maryland's State Board of Sign Language Interpreters by expanding its membership from seven to 11 members with specific representation requirements, including a deafblind individual, deaf community members, licensed interpreters from various settings (legal, medical, educational), and ex-officio members from disability and labor agencies. The bill requires the Board to establish licensing requirements for sign language interpreters by December 31, 2026 (previously July 1, 2024), and mandates interpreters to meet these standards by that date. It also adds new grounds for the Governor to remove board members, including two consecutive unexcused absences or failing to attend 50% of meetings annually. These changes aim to improve board diversity, clarify licensing timelines, and ensure board members meet ongoing eligibility criteria.
HB 1483 repeals Maryland's requirement for out-of-state clinical counselors to obtain a temporary telehealth license. It allows licensed counselors from other states to provide telehealth counseling to clients who relocated to Maryland (or returned after relocating), for up to six months, if they already had an established client-counselor relationship before the move. This exempts these counselors from Maryland's standard licensure rules during the six-month continuity period, but only for existing clients who relocated - not for new clients. The bill does not change regular licensing requirements for ongoing practice in Maryland.
SB 915 requires individuals performing limited X-ray procedures (such as chest, spine, and limb imaging) in Maryland to register with the State Board of Physicians. It restricts these operations to non-invasive X-rays only (excluding CT scans, mammography, or fluoroscopy) and mandates 115 hours of specialized training plus 6 months of clinical experience. The bill also establishes disciplinary procedures for violations and allows physician assistants to perform X-ray duties under physician supervision, while updating rules for cardiovascular specialists and medical graduates. This directly affects medical staff, radiologic technicians, and physician assistants conducting basic X-ray services in clinical settings.
SB 778 creates a new "clinical research pharmacy permit" required for pharmacies conducting clinical trials in Maryland. It allows healthcare providers to own such pharmacies under specific conditions, including requiring a licensed pharmacist to be on-site at all times and prohibiting owners from receiving payment for patient referrals. The bill also exempts clinical trials conducted by corporations from being classified as "practice of medicine," removing a licensing barrier for these activities. This directly affects pharmacies seeking to operate clinical trials, healthcare providers considering ownership, and the State Board of Pharmacy (as the permit issuer).